Inside informationEnglish
Update: Ipsen voluntarily withdraws Tazverik® (tazemetostat) in follicular lymphoma and epithelioid sarcoma
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Ipsen SA
- Filed
- 09/03/2026, 18:37
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 119084_20260309